“Because of COVID-19, surgeons are now performing laryngeal surgeries with longer instruments, full face guards and a gown. All these limit a surgeon’s dexterity. “We see demand for robotic solutions that improve dexterity or ability. With the Da Vinci robotic surgical assistant, one person can operate four or five laparoscopic rods alone during a surgery,” says Dave Saunders, Chief Technical Officer and Co-founder of Galen Robotics.”

“Based in Baltimore, US, Galen Robotics is developing a single-platform solution to aid surgeons across several surgical disciplines. They eliminate hand tremors, letting surgeons do more precise, minimally invasive surgical actions. John Hopkins University approached Galen in 2016 to commercialize their robotics research through the Robotic ENT Microsurgical System (REMS.) Since then, they’ve expanded on the same robotic technology. “We plan on getting Federal Drug Administration (FDA) approval next year and then we’ll go into sales. Medical students are currently getting training on virtual reality,” says Galen’s President and CEO, Bruce Lichorowic.“

“Galen wants to offer their robots on a service model to negate healthcare institutions’ high outlay costs. When offered as-a-service, they believe the greater versatility and wider application of surgical robots could spur a new demand level.”

“These new surgical robotics come at a time when hospitals are on the lookout for game-changing technology. Combined with the as-a-service model, Galen hopes to bring surgical robots to hospitals and care centers that could not previously afford the capital and operating costs.”

Read the full article featured on Kaspersky: https://bit.ly/3gsjbBv